Cercar

01/01/2023 Evaluation of cinematic volume rendering open-source and commercial solutions for the exploration of congenital heart data
Baseer, I, Valverde, I, Moustafa, AH, Blat, J, Camara, O. Evaluation of cinematic volume rendering open-source and commercial solutions for the exploration of congenital heart data. Ieee Visualization Conference. 2023; DOI:10.1109/VIS54172.2023.00024. PMID:. IF:(Q/D).
04/08/2025 Characterization and Prognostic Value of Longitudinal Strain in the Different Patterns of Takotsubo Syndrome
Sans-Roselló, J, Fernández-Peregrina, E, Montaner, PC, Sutil-Vega, M, Viladés-Medel, D, Rubio, PM, Kardenass, AE, Garcia-Hernando, V, Belmar-Cliville, D, Torres-Ruiz, G, Martínez-Rubio, A, García-García, HM. Characterization and Prognostic Value of Longitudinal Strain in the Different Patterns of Takotsubo Syndrome. ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES. 2025; 42(8)DOI:10.1111/echo.70256. PMID:40758261. IF:1.400(Q3/7D).
01/08/2025 Early diuretic response and outcome prediction in ambulatory worsening heart failure: Natriuresis versus diuresis
Marcos, MC, de la Espriella, R, Zegri-Reiriz, I, Llacer, P, Gracia, JR, Comín-Colet, J, Morales-Rull, JL, Diez-Villanueva, P, Baguda, JD, Jimenez-Marrero, S, Cortés, CO, Restrepo-Córdoba, MA, García-Pinilla, JM, Barrios, E, Díaz, SD, Núñez, J. Early diuretic response and outcome prediction in ambulatory worsening heart failure: Natriuresis versus diuresis. ESC Heart Failure. 2025; 12(4)DOI:10.1002/ehf2.15275. PMID:40152188. IF:3.700(Q1/3D).
01/08/2025 Initial Experience of Orthotopic Tricuspid Valve Replacement in Spain: TRI-SPA Replace Registry
Echarte-Morales, J, Barreiro-Pérez, M, Nombela-Franco, L, Freixa, X, Cruz-González, I, Sánchez-Recalde, A, Arzamendi, D, Baz, JA, Mon, M, Sanchis, L, Laffond, AE, Rodríguez, LMD, Li, CH, Jiménez, P, Altisent, OAJ, Blanco, F, Fernández-Golfin, C, Menduiña, I, Estévez-Loureiro, R. Initial Experience of Orthotopic Tricuspid Valve Replacement in Spain: TRI-SPA Replace Registry. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2025; 106(2)DOI:10.1002/ccd.31662. PMID:40464478. IF:2.100(Q3/6D).
01/08/2025 Impact of intensive versus nonintensive antithrombotic treatment on device-related thrombus after left atrial appendage closure
Garot, P, Cepas-Guillén, P, Flores-Umanzor, E, Leduc, N, Bajoras, V, Perrin, N, McInerney, A, Lafond, A, Farjat-Pasos, J, Millan, X, Zendjebil, S, Ibrahim, R, Salinas, P, de Backer, O, Cruz-González, I, Arzamendi, D, Sanchis, L, Nombela-Franco, L, OHara, G, Aminian, A, Nielsen-Kudsk, JE, Rodés-Cabau, J, Freixa, X. Impact of intensive versus nonintensive antithrombotic treatment on device-related thrombus after left atrial appendage closure. REVISTA ESPANOLA DE CARDIOLOGIA. 2025; 78(8)DOI:10.1016/j.rec.2024.11.006. PMID:39645198. IF:4.900(Q1/2D).
01/08/2025 Key priorities for the implementation of the 2023 ESC Guidelines for the management of endocarditis in low-resource settings
Borger, MA, de Waha, S, Marsan, NA, Zühlke, L, Mestres, CA, Fosbol, E, Bonaros, N, Pizzi, MN, Brida, M, Sionis, A, Delgado, V, Task Force ESC Guidelines Management endocarditis. Key priorities for the implementation of the 2023 ESC Guidelines for the management of endocarditis in low-resource settings. European Heart Journal-Quality of Care and Clinical Outcomes. 2025; 11(5)DOI:10.1093/ehjqcco/qcae106. PMID:40152919. IF:4.600(Q1/2D).
03/07/2025 Artificial intelligence for risk prediction in transcatheter heart valve interventions
Jamhour-Chelh, K, Arzamendi, D, Asmarats, L. Artificial intelligence for risk prediction in transcatheter heart valve interventions. Expert Review Of Cardiovascular Therapy. 2025; 23(7)DOI:10.1080/14779072.2025.2533241. PMID:40638096. IF:(Q/D).
01/07/2025 Use of ReCross to Increase Success Rate With Antegrade CTO PCI-A Multicenter Observational Study
Ayoub, M, Mozid, A, Philip, L, Millan, X, Khatri, J, Ungureanu, C, Bennett, J, Ghafari, C, Avran, A. Use of ReCross to Increase Success Rate With Antegrade CTO PCI-A Multicenter Observational Study. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2025; 106(1)DOI:10.1002/ccd.31585. PMID:40384369. IF:2.100(Q3/6D).